Trade Stoke Therapeutics, Inc. - STOK CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.12 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 8.68 |
| Open | 8.76 |
| 1-Year Change | 63.74% |
| Day's Range | 8.25 - 8.89 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 8.25 | -0.59 | -6.67% | 8.84 | 8.91 | 8.17 |
| Feb 20, 2025 | 8.68 | -0.52 | -5.65% | 9.20 | 9.28 | 8.44 |
| Feb 19, 2025 | 9.25 | -0.46 | -4.74% | 9.71 | 9.72 | 9.15 |
| Feb 18, 2025 | 9.64 | -0.98 | -9.23% | 10.62 | 11.00 | 9.64 |
| Feb 14, 2025 | 10.64 | 0.18 | 1.72% | 10.46 | 10.98 | 10.46 |
| Feb 13, 2025 | 10.57 | 0.46 | 4.55% | 10.11 | 10.59 | 9.94 |
| Feb 12, 2025 | 10.21 | 0.30 | 3.03% | 9.91 | 10.26 | 9.83 |
| Feb 11, 2025 | 10.27 | 0.28 | 2.80% | 9.99 | 10.30 | 9.69 |
| Feb 10, 2025 | 10.20 | -0.88 | -7.94% | 11.08 | 11.37 | 9.92 |
| Feb 7, 2025 | 11.30 | -1.36 | -10.74% | 12.66 | 12.84 | 11.23 |
| Feb 6, 2025 | 12.70 | 0.04 | 0.32% | 12.66 | 12.78 | 12.40 |
| Feb 5, 2025 | 12.66 | 0.10 | 0.80% | 12.56 | 12.86 | 12.46 |
| Feb 4, 2025 | 12.53 | 1.53 | 13.91% | 11.00 | 12.70 | 10.95 |
| Feb 3, 2025 | 11.47 | 0.50 | 4.56% | 10.97 | 11.72 | 10.97 |
| Jan 31, 2025 | 11.42 | 0.68 | 6.33% | 10.74 | 11.67 | 10.74 |
| Jan 30, 2025 | 10.94 | 0.45 | 4.29% | 10.49 | 11.09 | 10.47 |
| Jan 29, 2025 | 10.46 | 0.75 | 7.72% | 9.71 | 10.78 | 9.68 |
| Jan 28, 2025 | 9.77 | -0.56 | -5.42% | 10.33 | 10.46 | 9.68 |
| Jan 27, 2025 | 10.52 | 0.13 | 1.25% | 10.39 | 11.04 | 10.30 |
| Jan 24, 2025 | 10.56 | 0.08 | 0.76% | 10.48 | 10.78 | 10.35 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Stoke Therapeutics, Inc. Company profile
About Stoke Therapeutics Inc
Stoke Therapeutics, Inc. is a biotechnology company. It focuses to treat the underlying causes of severe genetic diseases by upregulating protein expression. It is developing antisense oligonucleotide (ASO) medicines that target ribonucleic acid (RNA) and modulate precursor-messenger RNA (pre-mRNA) splicing to upregulate protein expression where needed and with appropriate specificity to near normal levels. It focuses to develop the precision medicine platform to target the underlying cause of a spectrum of genetic diseases in which the patient has healthy copy of a gene and mutated copy that fails to produce a protein essential to health. It utilizes its technology platform, Targeted Augmentation of Nuclear Gene Output (TANGO) to design ASOs to upregulate the expression of protein by individual genes in a patient. Its product candidate, STK-001, is offered to treat Dravet syndrome. Its research platform is designed to address protein deficiency.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Stoke Therapeutics Inc revenues was not reported. Net loss increased 64% to $85.8M. Higher net loss reflects Research and development - Balancing val increase of 58% to $48M (expense), Stock-based Compensation in SGA increase from $3.9M to $10.2M (expense), General and administrative - Balancing increase of 28% to $21.7M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
45 Wiggins Avenue
BEDFORD
MASSACHUSETTS 01730
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com